Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL) announced its quarterly earnings results on Tuesday. The company reported $0.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.29. The business earned $707.80 million during the quarter, compared to the consensus estimate of $653.40 million. Hanwha Q Cells Co. had a net margin of 8.03% and a return on equity of 42.12%. The business’s quarterly revenue was up 65.7% compared to the same quarter last year.

Hanwha Q Cells Co. (NASDAQ:HQCL) opened at 9.24 on Thursday. Hanwha Q Cells Co. has a 52-week low of $8.84 and a 52-week high of $9.33. The company’s 50 day moving average is $10.73 and its 200-day moving average is $12.22.

Earnings History for Hanwha Q Cells Co. (NASDAQ:HQCL)

Hedge funds have recently made changes to their positions in the stock. Guggenheim Capital LLC increased its stake in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock valued at $7,108,000 after buying an additional 107,408 shares during the period. Morgan Stanley increased its stake in shares of Hanwha Q Cells Co. by 12.8% in the third quarter. Morgan Stanley now owns 181,537 shares of the company’s stock valued at $2,035,000 after buying an additional 20,545 shares during the period. Barclays PLC acquired a new stake in shares of Hanwha Q Cells Co. during the first quarter valued at about $432,000. Oxford Asset Management acquired a new stake in shares of Hanwha Q Cells Co. during the second quarter valued at about $392,000. Finally, KBC Group NV increased its stake in shares of Hanwha Q Cells Co. by 36.3% in the third quarter. KBC Group NV now owns 17,098 shares of the company’s stock valued at $192,000 after buying an additional 4,554 shares during the period. 1.61% of the stock is currently owned by institutional investors.

A number of analysts have recently issued reports on the stock. Roth Capital downgraded shares of Hanwha Q Cells Co. from a “buy” rating to a “neutral” rating in a report on Friday, August 5th. Zacks Investment Research downgraded shares of Hanwha Q Cells Co. from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 9th.

TRADEMARK VIOLATION WARNING: “Hanwha Q Cells Co. Ltd. (HQCL) Posts Earnings Results, Beats Expectations By $0.29 EPS” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international trademark and copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2016/11/24/hanwha-q-cells-co-ltd-hqcl-posts-earnings-results-beats-expectations-by-0-29-eps.html.

About Hanwha Q Cells Co.

Hanwha Q CELLS Co, Ltd., formerly Hanwha SolarOne Co, Ltd., is a global solar energy company engaged in the manufacturing of solar modules, and the development and management of downstream solar farms. It manufactures a range of photo voltaic (PV) cells and PV modules at its manufacturing facilities in China and Malaysia using manufacturing process technologies, including those developed at its research and development facilities in Germany.

5 Day Chart for NASDAQ:HQCL

Receive News & Stock Ratings for Hanwha Q Cells Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanwha Q Cells Co. Ltd. and related stocks with our FREE daily email newsletter.